Press Releases

 
Press Releases
  Date Title and Summary View
Aug 6, 2014
SAN DIEGO, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) biomarker analysis, today announced that Amy McNeal has joined the Company as Senior Director of Managed Care and Reimbursement Strategies. Ms. McN...
Jun 2, 2014
Blood-based OncoCEE-BR™ Platform now Includes Estrogen Receptor Testing SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating tumor cells (CTCs), today announced the launch of its estrogen recep...
May 19, 2014
SAN DIEGO, May 19, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and Circulating Tumor Cells (CTCs), today announced the recruitment of a national sales team to support the commercialization of its OncoCEE™ services. ...
May 7, 2014
SAN DIEGO, May 7, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular diagnostics company specializing in oncology biomarker detection and monitoring through circulating tumor cells (CTCs) and cell-free circulating tumor DNA, today announced that it has closed a loan facility of up to $10 million (the "facility") with Oxford Finance L...
Apr 28, 2014
SAN DIEGO, April 28, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular diagnostics company specializing in oncology biomarker detection and monitoring through circulating tumor cells (CTCs) and cell-free circulating tumor DNA, today announced the launch of its clinical research services offering. This service will be perform...
Mar 24, 2014
SAN DIEGO, March 24, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) and biomarker analysis, today announced that it has appointed Raaj Trivedi as Vice President - Commercial Operations. Mr. Trivedi has more than 15 years...
Mar 5, 2014
SAN DIEGO, March 5, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), an oncology diagnostics company focused on improving individual patient treatment, announced today that the Company's President and Chief Executive Officer, Michael Nall will be presenting at the 26th Annual ROTH Conference, being held March 10-12, 2014 at the Ritz-Carlton in...
Feb 10, 2014
SAN DIEGO, Feb. 10, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), an oncology diagnostics company focused on improving individual patient treatment, announced today the closing of its previously announced initial public offering of 1,900,000 shares of common stock, at a public offering price of $10.00 per share. The gross proceeds to Biocep...
Feb 4, 2014
SAN DIEGO, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc., an oncology diagnostics company focused on improving individual patient treatment, today announced the pricing of its initial public offering of 1,900,000 shares of its common stock offered at a price to the public of $10.00 per share. The gross proceeds to Biocept from the initial public o...
Nov 5, 2013
SAN DIEGO, November 5, 2013 — Biocept, Inc., today announced the appointment of Marsha A. Chandler, Ph.D. and Bruce A. Huebner as independent directors. Dr.  Chandler is currently the Executive Vice President and Chief Operating Officer of the Salk Institute for Biological Studies. She manages approximately 1000 scientific and...
Page: FirstPrevious ...
16
NextLast
= add release to Briefcase